1 min read
Meet Veristat at BIO-Europe Spring: March 23-25, 2026 - Lisbon, Portugal
🔬 Connecting with the Global Biopharma Community
Veristat is pleased to attend BIO-Europe Spring, where biotech...
This year marks the eighth year that Team Veristat participated in Memorial Sloan Kettering's Cycle for Survival, the movement to beat rare cancers. Founded in partnership with Equinox fitness club sixteen years ago, this ground-breaking research fundraiser has raised nearly 300 million dollars for rare cancer research to date.
Veristat is so passionate about Cycle for Survival because 100% of the funds raised go directly to rare cancer research within six months. And that research doesn't only benefit MSK patients; it advances and lifts up the technology, and most importantly, the hope, for rare cancer patients everywhere. This aligns with Veristat’s key goal to bring rare cancer therapies to patients sooner!
Veristat is raising money for Cycle for Survival, the movement to beat rare cancers. Will you donate to help us go above and beyond our fundraising goal?
Help our team by donating today to give people facing rare cancers hope for a better future. Around half of all people diagnosed with cancer have a rare form of the disease. Since 2007, the Cycle for Survival community has provided funding to hundreds of doctors and scientists in pursuit of bold ideas. From FDA approval of new drugs to the development of innovative diagnostic tools, Cycle for Survival–funded breakthroughs are transforming the way rare cancers are treated around the world.
Your support makes so much possible. Together we will continue to fight until every person with a rare cancer has a way to treat — or beat — their disease.
1 min read
Mar 23, 2026 Veristat Events
🔬 Connecting with the Global Biopharma Community
Veristat is pleased to attend BIO-Europe Spring, where biotech...
1 min read
Mar 18, 2026 Veristat Events
🔬 Connecting with the Global Clinical Data and Biostatistics Community
Veristat is pleased to attend PHUSE US Connect...